Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

Specific changes in faecal microbiota are associated with familial Mediterranean fever.

Deshayes S, Fellahi S, Bastard JP, Launay JM, Callebert J, Fraisse T, Buob D, Boffa JJ, Giurgea I, Dupont C, Jegou S, Straube M, Karras A, Aouba A, Grateau G, Sokol H, Georgin-Lavialle S; AA Amyloidosis Study Group; AA amyloidosis Study Group.

Ann Rheum Dis. 2019 Aug 3. pii: annrheumdis-2019-215258. doi: 10.1136/annrheumdis-2019-215258. [Epub ahead of print]

PMID:
31377728
2.

Baseline microbiota composition modulates antibiotic-mediated effects on the gut microbiota and host.

Lavelle A, Hoffmann TW, Pham HP, Langella P, Guédon E, Sokol H.

Microbiome. 2019 Aug 2;7(1):111. doi: 10.1186/s40168-019-0725-3.

3.

Oral delivery of Pancreatitis-Associated Protein by Lactococcus lactis displays protective effects in DNBS-induced colitis model and is able to modulate the composition of the microbiota.

Breyner NM, Boas PBV, Fernandes G, de Carvalho RD, Rochat T, Michel ML, Chain F, Sokol H, de Azevedo M, Myioshi A, Azevedo VA, Langella P, Bermúdez-Humarán LG, Chatel JM.

Environ Microbiol. 2019 Jul 19. doi: 10.1111/1462-2920.14748. [Epub ahead of print]

PMID:
31325218
4.
5.

Fecal Microbiota Transplantation for Ulcerative Colitis.

Benech N, Kapel N, Sokol H.

JAMA. 2019 Jun 11;321(22):2240. doi: 10.1001/jama.2019.3946. No abstract available.

PMID:
31184729
6.

Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.

Rivas MA, Avila BE, Koskela J, Huang H, Stevens C, Pirinen M, Haritunians T, Neale BM, Kurki M, Ganna A, Graham D, Glaser B, Peter I, Atzmon G, Barzilai N, Levine AP, Schiff E, Pontikos N, Weisburd B, Lek M, Karczewski KJ, Bloom J, Minikel EV, Petersen BS, Beaugerie L, Seksik P, Cosnes J, Schreiber S, Bokemeyer B, Bethge J; International IBD Genetics Consortium; NIDDK IBD Genetics Consortium; T2D-GENES Consortium, Heap G, Ahmad T, Plagnol V, Segal AW, Targan S, Turner D, Saavalainen P, Farkkila M, Kontula K, Palotie A, Brant SR, Duerr RH, Silverberg MS, Rioux JD, Weersma RK, Franke A, Jostins L, Anderson CA, Barrett JC, MacArthur DG, Jalas C, Sokol H, Xavier RJ, Pulver A, Cho JH, McGovern DPB, Daly MJ.

PLoS Genet. 2019 May 30;15(5):e1008190. doi: 10.1371/journal.pgen.1008190. eCollection 2019 May.

7.

Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's disease.

Sokol H, Brot L, Stefanescu C, Auzolle C, Barnich N, Buisson A, Fumery M, Pariente B, Le Bourhis L, Treton X, Nancey S, Allez M, Seksik P; REMIND Study Group Investigators.

Gut. 2019 May 29. pii: gutjnl-2019-318719. doi: 10.1136/gutjnl-2019-318719. [Epub ahead of print]

PMID:
31142586
8.

Preparation of AgNPs/saponite nanocomposites without reduction agents and study of its antibacterial activity.

Sprynskyy M, Sokol H, Rafińska K, Brzozowska W, Railean-Plugaru V, Pomastowski P, Buszewski B.

Colloids Surf B Biointerfaces. 2019 Aug 1;180:457-465. doi: 10.1016/j.colsurfb.2019.04.066. Epub 2019 May 1.

PMID:
31100672
9.

Nancy Index Scores of Chronic Inflammatory Bowel Disease Activity Associate With Development of Colorectal Neoplasia.

Kirchgesner J, Svrcek M, Le Gall G, Landman C, Dray X, Bourrier A, Nion-Larmurier I, Hoyeau N, Sokol H, Seksik P, Cosnes J, Fléjou JF, Beaugerie L; Saint-Antoine Inflammatory Bowel Disease Network.

Clin Gastroenterol Hepatol. 2019 May 11. pii: S1542-3565(19)30511-7. doi: 10.1016/j.cgh.2019.05.002. [Epub ahead of print]

PMID:
31085339
10.

Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.

Lemoinne S, Kemgang A, Ben Belkacem K, Straube M, Jegou S, Corpechot C; Saint-Antoine IBD Network, Chazouillères O, Housset C, Sokol H.

Gut. 2019 Apr 19. pii: gutjnl-2018-317791. doi: 10.1136/gutjnl-2018-317791. [Epub ahead of print]

PMID:
31003979
11.

[Tryptophan and metabolic syndrome, a new challenge for health].

Agus A, Sokol H.

Med Sci (Paris). 2019 Mar;35(3):213-215. doi: 10.1051/medsci/2019040. Epub 2019 Apr 1. French. No abstract available.

PMID:
30931904
12.

Molybdenum Trioxide (α-MoO3) Nanoribbons for Ultrasensitive Ammonia (NH3) Gas Detection: Integrated Experimental and Density Functional Theory Simulation Studies.

Kwak D, Wang M, Koski KJ, Zhang L, Sokol H, Maric R, Lei Y.

ACS Appl Mater Interfaces. 2019 Mar 20;11(11):10697-10706. doi: 10.1021/acsami.8b20502. Epub 2019 Mar 11.

PMID:
30854851
13.

Genetic effects on the commensal microbiota in inflammatory bowel disease patients.

Aschard H, Laville V, Tchetgen ET, Knights D, Imhann F, Seksik P, Zaitlen N, Silverberg MS, Cosnes J, Weersma RK, Xavier R, Beaugerie L, Skurnik D, Sokol H.

PLoS Genet. 2019 Mar 8;15(3):e1008018. doi: 10.1371/journal.pgen.1008018. eCollection 2019 Mar.

14.

The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases.

Richard ML, Sokol H.

Nat Rev Gastroenterol Hepatol. 2019 Jun;16(6):331-345. doi: 10.1038/s41575-019-0121-2. Review.

PMID:
30824884
15.

Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.

Walker GJ, Harrison JW, Heap GA, Voskuil MD, Andersen V, Anderson CA, Ananthakrishnan AN, Barrett JC, Beaugerie L, Bewshea CM, Cole AT, Cummings FR, Daly MJ, Ellul P, Fedorak RN, Festen EAM, Florin TH, Gaya DR, Halfvarson J, Hart AL, Heerasing NM, Hendy P, Irving PM, Jones SE, Koskela J, Lindsay JO, Mansfield JC, McGovern D, Parkes M, Pollok RCG, Ramakrishnan S, Rampton DS, Rivas MA, Russell RK, Schultz M, Sebastian S, Seksik P, Singh A, So K, Sokol H, Subramaniam K, Todd A, Annese V, Weersma RK, Xavier R, Ward R, Weedon MN, Goodhand JR, Kennedy NA, Ahmad T; IBD Pharmacogenetics Study Group.

JAMA. 2019 Feb 26;321(8):773-785. doi: 10.1001/jama.2019.0709. Erratum in: JAMA. 2019 Apr 23;321(16):1636.

PMID:
30806694
16.

T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrence.

Allez M, Auzolle C, Ngollo M, Bottois H, Chardiny V, Corraliza AM, Salas A, Perez K, Stefanescu C, Nancey S, Buisson A, Pariente B, Fumery M, Sokol H, Tréton X, Barnich N, Seksik P, Le Bourhis L; REMIND Study Group.

Gut. 2019 Feb 12. pii: gutjnl-2018-317878. doi: 10.1136/gutjnl-2018-317878. [Epub ahead of print]

PMID:
30792246
17.

Faecalibacterium prausnitzii Skews Human DC to Prime IL10-Producing T Cells Through TLR2/6/JNK Signaling and IL-10, IL-27, CD39, and IDO-1 Induction.

Alameddine J, Godefroy E, Papargyris L, Sarrabayrouse G, Tabiasco J, Bridonneau C, Yazdanbakhsh K, Sokol H, Altare F, Jotereau F.

Front Immunol. 2019 Feb 6;10:143. doi: 10.3389/fimmu.2019.00143. eCollection 2019.

18.

Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria.

Battipaglia G, Malard F, Rubio MT, Ruggeri A, Mamez AC, Brissot E, Giannotti F, Dulery R, Joly AC, Baylatry MT, Kossmann MJ, Tankovic J, Beaugerie L, Sokol H, Mohty M.

Haematologica. 2019 Aug;104(8):1682-1688. doi: 10.3324/haematol.2018.198549. Epub 2019 Feb 7.

19.

Validation of a global quantitative analysis methodology of tryptophan metabolites in mice using LC-MS.

Lefèvre A, Mavel S, Nadal-Desbarats L, Galineau L, Attucci S, Dufour D, Sokol H, Emond P.

Talanta. 2019 Apr 1;195:593-598. doi: 10.1016/j.talanta.2018.11.094. Epub 2018 Nov 27.

PMID:
30625588
20.

Diet-Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice.

Debray D, El Mourabit H, Merabtene F, Brot L, Ulveling D, Chrétien Y, Rainteau D, Moszer I, Wendum D, Sokol H, Housset C.

Hepatol Commun. 2018 Oct 10;2(12):1533-1549. doi: 10.1002/hep4.1266. eCollection 2018 Dec.

21.

Inhibitory Effect of Ursodeoxycholic Acid on Clostridium difficile Germination Is Insufficient to Prevent Colitis: A Study in Hamsters and Humans.

Palmieri LJ, Rainteau D, Sokol H, Beaugerie L, Dior M, Coffin B, Humbert L, Eguether T, Bado A, Hoys S, Janoir C, Duboc H.

Front Microbiol. 2018 Nov 22;9:2849. doi: 10.3389/fmicb.2018.02849. eCollection 2018.

22.

Correction: Interleukin-22-deficiency and microbiota contribute to the exacerbation of Toxoplasma gondii-induced intestinal inflammation.

Couturier-Maillard A, Froux N, Piotet-Morin J, Michaudel C, Brault L, Le Bérichel J, Sénéchal A, Robinet P, Chenuet P, Jejou S, Dumoutier L, Renauld JC, Iovanna J, Huber S, Chamaillard M, Quesniaux VFJ, Sokol H, Ryffel B.

Mucosal Immunol. 2019 Jan;12(1):290. doi: 10.1038/s41385-018-0112-6.

PMID:
30504789
23.

Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice.

Hendrikx T, Duan Y, Wang Y, Oh JH, Alexander LM, Huang W, Stärkel P, Ho SB, Gao B, Fiehn O, Emond P, Sokol H, van Pijkeren JP, Schnabl B.

Gut. 2019 Aug;68(8):1504-1515. doi: 10.1136/gutjnl-2018-317232. Epub 2018 Nov 17.

PMID:
30448775
24.

Intestinal dysbiosis in inflammatory bowel disease associated with primary immunodeficiency.

Sokol H, Mahlaoui N, Aguilar C, Bach P, Join-Lambert O, Garraffo A, Seksik P, Danion F, Jegou S, Straube M, Lenoir C, Neven B, Moshous D, Blanche S, Pigneur B, Goulet O, Ruemmele F, Suarez F, Beaugerie L, Pannier S, Mazingue F, Lortholary O, Galicier L, Picard C, de Saint Basile G, Latour S, Fischer A.

J Allergy Clin Immunol. 2019 Feb;143(2):775-778.e6. doi: 10.1016/j.jaci.2018.09.021. Epub 2018 Oct 10. No abstract available.

PMID:
30312711
25.

The regenerating family member 3 β instigates IL-17A-mediated neutrophil recruitment downstream of NOD1/2 signalling for controlling colonisation resistance independently of microbiota community structure.

Waldschmitt N, Kitamoto S, Secher T, Zacharioudaki V, Boulard O, Floquet E, Delacre M, Lamas B, Pham HP, Six A, Richard ML, Dagorn JC, Eberl G, Langella P, Chatel JM, Ryffel B, Iovanna JL, Poulin LF, Sokol H, Kamada N, Chamaillard M.

Gut. 2019 Jul;68(7):1190-1199. doi: 10.1136/gutjnl-2018-316757. Epub 2018 Oct 2.

PMID:
30279238
26.

Enterobacteriaceae are essential for the modulation of colitis severity by fungi.

Sovran B, Planchais J, Jegou S, Straube M, Lamas B, Natividad JM, Agus A, Dupraz L, Glodt J, Da Costa G, Michel ML, Langella P, Richard ML, Sokol H.

Microbiome. 2018 Sep 1;6(1):152. doi: 10.1186/s40168-018-0538-9.

27.

Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease.

Le Gall G, Kirchgesner J, Bejaoui M, Landman C, Nion-Larmurier I, Bourrier A, Sokol H, Seksik P, Beaugerie L.

PLoS One. 2018 Aug 31;13(8):e0201991. doi: 10.1371/journal.pone.0201991. eCollection 2018.

28.

Clinical and multi-omics cross-phenotyping of patients with autoimmune and autoinflammatory diseases: the observational TRANSIMMUNOM protocol.

Lorenzon R, Mariotti-Ferrandiz E, Aheng C, Ribet C, Toumi F, Pitoiset F, Chaara W, Derian N, Johanet C, Drakos I, Harris S, Amselem S, Berenbaum F, Benveniste O, Bodaghi B, Cacoub P, Grateau G, Amouyal C, Hartemann A, Saadoun D, Sellam J, Seksik P, Sokol H, Salem JE, Vicaut E, Six A, Rosenzwajg M, Bernard C, Klatzmann D.

BMJ Open. 2018 Aug 30;8(8):e021037. doi: 10.1136/bmjopen-2017-021037.

29.

Inter-kingdom effect on epithelial cells of the N-Acyl homoserine lactone 3-oxo-C12:2, a major quorum-sensing molecule from gut microbiota.

Landman C, Grill JP, Mallet JM, Marteau P, Humbert L, Le Balc'h E, Maubert MA, Perez K, Chaara W, Brot L, Beaugerie L, Sokol H, Thenet S, Rainteau D, Seksik P, Quévrain E; Saint Antoine IBD Network.

PLoS One. 2018 Aug 29;13(8):e0202587. doi: 10.1371/journal.pone.0202587. eCollection 2018.

30.

Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome.

Natividad JM, Agus A, Planchais J, Lamas B, Jarry AC, Martin R, Michel ML, Chong-Nguyen C, Roussel R, Straube M, Jegou S, McQuitty C, Le Gall M, da Costa G, Lecornet E, Michaudel C, Modoux M, Glodt J, Bridonneau C, Sovran B, Dupraz L, Bado A, Richard ML, Langella P, Hansel B, Launay JM, Xavier RJ, Duboc H, Sokol H.

Cell Metab. 2018 Nov 6;28(5):737-749.e4. doi: 10.1016/j.cmet.2018.07.001. Epub 2018 Jul 26.

PMID:
30057068
31.

Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice.

Natividad JM, Lamas B, Pham HP, Michel ML, Rainteau D, Bridonneau C, da Costa G, van Hylckama Vlieg J, Sovran B, Chamignon C, Planchais J, Richard ML, Langella P, Veiga P, Sokol H.

Nat Commun. 2018 Jul 18;9(1):2802. doi: 10.1038/s41467-018-05249-7.

32.

Gut Microbiota-Stimulated Innate Lymphoid Cells Support β-Defensin 14 Expression in Pancreatic Endocrine Cells, Preventing Autoimmune Diabetes.

Miani M, Le Naour J, Waeckel-Enée E, Verma SC, Straube M, Emond P, Ryffel B, van Endert P, Sokol H, Diana J.

Cell Metab. 2018 Oct 2;28(4):557-572.e6. doi: 10.1016/j.cmet.2018.06.012. Epub 2018 Jul 12.

PMID:
30017352
33.

Expression of CCR6 and CXCR6 by Gut-Derived CD4+/CD8α+ T-Regulatory Cells, Which Are Decreased in Blood Samples From Patients With Inflammatory Bowel Diseases.

Godefroy E, Alameddine J, Montassier E, Mathé J, Desfrançois-Noël J, Marec N, Bossard C, Jarry A, Bridonneau C, Le Roy A, Sarrabayrouse G, Kerdreux E, Bourreille A, Sokol H, Jotereau F, Altare F.

Gastroenterology. 2018 Oct;155(4):1205-1217. doi: 10.1053/j.gastro.2018.06.078. Epub 2018 Jul 5.

PMID:
29981781
34.

Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health.

Laurans L, Venteclef N, Haddad Y, Chajadine M, Alzaid F, Metghalchi S, Sovran B, Denis RGP, Dairou J, Cardellini M, Moreno-Navarrete JM, Straub M, Jegou S, McQuitty C, Viel T, Esposito B, Tavitian B, Callebert J, Luquet SH, Federici M, Fernandez-Real JM, Burcelin R, Launay JM, Tedgui A, Mallat Z, Sokol H, Taleb S.

Nat Med. 2018 Aug;24(8):1113-1120. doi: 10.1038/s41591-018-0060-4. Epub 2018 Jun 25.

PMID:
29942089
35.

Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease.

Agus A, Planchais J, Sokol H.

Cell Host Microbe. 2018 Jun 13;23(6):716-724. doi: 10.1016/j.chom.2018.05.003. Review.

36.

Nucleotide-Binding Domain Leucine-Rich Repeat Containing Proteins and Intestinal Microbiota: Pivotal Players in Colitis and Colitis-Associated Cancer Development.

Prossomariti A, Sokol H, Ricciardiello L.

Front Immunol. 2018 May 14;9:1039. doi: 10.3389/fimmu.2018.01039. eCollection 2018. Review.

37.

Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.

Rivas MA, Avila BE, Koskela J, Huang H, Stevens C, Pirinen M, Haritunians T, Neale BM, Kurki M, Ganna A, Graham D, Glaser B, Peter I, Atzmon G, Barzilai N, Levine AP, Schiff E, Pontikos N, Weisburd B, Lek M, Karczewski KJ, Bloom J, Minikel EV, Petersen BS, Beaugerie L, Seksik P, Cosnes J, Schreiber S, Bokemeyer B, Bethge J; International IBD Genetics Consortium; NIDDK IBD Genetics Consortium; T2D-GENES Consortium, Heap G, Ahmad T, Plagnol V, Segal AW, Targan S, Turner D, Saavalainen P, Farkkila M, Kontula K, Palotie A, Brant SR, Duerr RH, Silverberg MS, Rioux JD, Weersma RK, Franke A, Jostins L, Anderson CA, Barrett JC, MacArthur DG, Jalas C, Sokol H, Xavier RJ, Pulver A, Cho JH, McGovern DPB, Daly MJ.

PLoS Genet. 2018 May 24;14(5):e1007329. doi: 10.1371/journal.pgen.1007329. eCollection 2018 May. Erratum in: PLoS Genet. 2019 May 30;15(5):e1008190.

38.

Interleukin-22-deficiency and microbiota contribute to the exacerbation of Toxoplasma gondii-induced intestinal inflammation.

Couturier-Maillard A, Froux N, Piotet-Morin J, Michaudel C, Brault L, Le Bérichel J, Sénéchal A, Robinet P, Chenuet P, Jejou S, Dumoutier L, Renauld JC, Iovanna J, Huber S, Chamaillard M, Quesniaux V, Sokol H, Chamaillard M, Ryffel B.

Mucosal Immunol. 2018 Jul;11(4):1181-1190. doi: 10.1038/s41385-018-0005-8. Epub 2018 May 4. Erratum in: Mucosal Immunol. 2019 Jan;12(1):290.

PMID:
29728643
39.

Differences in epidemiological features between ulcerative colitis and Crohn's disease: The early life-programmed versus late dysbiosis hypothesis.

Beaugerie L, Langholz E, Nyboe-Andersen N, Pigneur B, Sokol H; ECCO Epicom.

Med Hypotheses. 2018 Jun;115:19-21. doi: 10.1016/j.mehy.2018.03.009. Epub 2018 Mar 23.

40.

A Versatile New Model of Chemically Induced Chronic Colitis Using an Outbred Murine Strain.

Barone M, Chain F, Sokol H, Brigidi P, Bermúdez-Humarán LG, Langella P, Martín R.

Front Microbiol. 2018 Mar 27;9:565. doi: 10.3389/fmicb.2018.00565. eCollection 2018.

41.

Aryl hydrocarbon receptor and intestinal immunity.

Lamas B, Natividad JM, Sokol H.

Mucosal Immunol. 2018 Jul;11(4):1024-1038. doi: 10.1038/s41385-018-0019-2. Epub 2018 Apr 7. Review.

PMID:
29626198
42.

Phages infecting Faecalibacterium prausnitzii belong to novel viral genera that help to decipher intestinal viromes.

Cornuault JK, Petit MA, Mariadassou M, Benevides L, Moncaut E, Langella P, Sokol H, De Paepe M.

Microbiome. 2018 Apr 3;6(1):65. doi: 10.1186/s40168-018-0452-1.

43.

Gut microbiota: Beyond metagenomics, metatranscriptomics illuminates microbiome functionality in IBD.

Lavelle A, Sokol H.

Nat Rev Gastroenterol Hepatol. 2018 Apr;15(4):193-194. doi: 10.1038/nrgastro.2018.15. Epub 2018 Feb 21. No abstract available.

PMID:
29463904
44.

Roux-en-Y Gastric-Bypass and sleeve gastrectomy induces specific shifts of the gut microbiota without altering the metabolism of bile acids in the intestinal lumen.

Duboc H, Nguyen CC, Cavin JB, Ribeiro-Parenti L, Jarry AC, Rainteau D, Humbert L, Coffin B, Le Gall M, Bado A, Sokol H.

Int J Obes (Lond). 2019 Feb;43(2):428-431. doi: 10.1038/s41366-018-0015-3. Epub 2018 Jan 30.

PMID:
29453461
45.

[Gut microbiota: What impact on colorectal carcinogenesis and treatment?]

Bruneau A, Baylatry MT, Joly AC, Sokol H.

Bull Cancer. 2018 Jan;105(1):70-80. doi: 10.1016/j.bulcan.2017.10.025. Epub 2017 Dec 6. Review. French.

PMID:
29217301
46.

Probiotic Strain Lactobacillus casei BL23 Prevents Colitis-Associated Colorectal Cancer.

Jacouton E, Chain F, Sokol H, Langella P, Bermúdez-Humarán LG.

Front Immunol. 2017 Nov 17;8:1553. doi: 10.3389/fimmu.2017.01553. eCollection 2017.

47.

Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study.

Martineau C, Flourié B, Wils P, Vaysse T, Altwegg R, Buisson A, Amiot A, Pineton de Chambrun G, Abitbol V, Fumery M, Hébuterne X, Viennot S, Laharie D, Beaugerie L, Nancey S, Sokol H; Goli-Crohn Study Group.

Aliment Pharmacol Ther. 2017 Dec;46(11-12):1077-1084. doi: 10.1111/apt.14371. Epub 2017 Oct 13.

48.

New Insights into the Diversity of the Genus Faecalibacterium.

Benevides L, Burman S, Martin R, Robert V, Thomas M, Miquel S, Chain F, Sokol H, Bermudez-Humaran LG, Morrison M, Langella P, Azevedo VA, Chatel JM, Soares S.

Front Microbiol. 2017 Sep 22;8:1790. doi: 10.3389/fmicb.2017.01790. eCollection 2017.

49.

Microbiota in digestive cancers: our new partner?

Lopez A, Hansmannel F, Kokten T, Bronowicki JP, Melhem H, Sokol H, Peyrin-Biroulet L.

Carcinogenesis. 2017 Dec 7;38(12):1157-1166. doi: 10.1093/carcin/bgx087. Review.

PMID:
28968883
50.

Experimental colitis delays and reduces the severity of collagen-induced arthritis in mice.

Hablot J, Peyrin-Biroulet L, Kokten T, El Omar R, Netter P, Bastien C, Jouzeau JY, Sokol H, Moulin D.

PLoS One. 2017 Sep 19;12(9):e0184624. doi: 10.1371/journal.pone.0184624. eCollection 2017.

Supplemental Content

Support Center